CA9 and brain neoplasm: In addition, the treatment of glioblastoma xenografts by CAIX inhibitor SLC-0111 in combination with temozolomide significantly decreased expression of stem cell markers and reduced the percentage of brain tumor-initiating cells (TICs) and neurosphere formation capacity [42].